Artificial intelligence tools secure tomorrow’s electric grid
Oak Ridge National Laboratory has launched a program designed to accelerate deployment of innovations that may help fight the COVID-19 pandemic. The COVID-19 Rapid Access Licensing Program will allow companies to license these select technologies at no cost for one year.
COVID-19 has upended nearly every aspect of our daily lives and forced us all to rethink how we can continue our work in a more physically isolated world.
Juergen Rapp, a distinguished R&D staff scientist in ORNL’s Fusion Energy Division in the Nuclear Science and Engineering Directorate, has been named a fellow of the American Nuclear Society
ORNL welcomed six technology innovators to join the fourth cohort of Innovation Crossroads, the Southeast’s only entrepreneurial research and development program based at a U.S. Department of Energy national laboratory.
A team led by the Department of Energy’s Oak Ridge National Laboratory synthesized a tiny structure with high surface area and discovered how its unique architecture drives ions across interfaces to transport energy or information.
Matthew R. Ryder, a researcher at the Department of Energy’s Oak Ridge National Laboratory, has been named the 2020 Foresight Fellow in Molecular-Scale Engineering.
Temperatures hotter than the center of the sun. Magnetic fields hundreds of thousands of times stronger than the earth’s. Neutrons energetic enough to change the structure of a material entirely.
Scientists have found a new method to strategically add deuterium to benzene, an aromatic compound commonly found in crude oil. When applied to the active ingredient of drugs to incorporate deuterium, it could dramatically improve the drugs’ efficacy and safety and even introduce new medicines.
ITER, the world’s largest international scientific collaboration, is beginning assembly of the fusion reactor tokamak that will include 12 different essential hardware systems provided by US ITER, which is managed by Oak Ridge National Laboratory.
Oak Ridge National Laboratory researchers have discovered a better way to separate actinium-227, a rare isotope essential for an FDA-approved cancer treatment.